Thermo Fisher Scientific (TMO) Income from Non-Controlling Interests (2021 - 2026)
Thermo Fisher Scientific (TMO) posted Income from Non-Controlling Interests of $5.0 million for Q1 2026, down 16.67% quarter-over-quarter from $6.0 million in Q4 2025, and up 25.0% year-on-year from $4.0 million in Q1 2025.
Thermo Fisher Scientific (TMO) Income from Non-Controlling Interests (2021 - 2026) Analysis & Trends
Thermo Fisher Scientific (TMO) has reported Income from Non-Controlling Interests for 6 consecutive years, with $5.0 million the latest figure, recorded in Q1 2026.
- Income from Non-Controlling Interests for Q1 2026 came in at $5.0 million, up 25.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $18.0 million (up 350.0% YoY), and the FY2025 annual result was $17.0 million, up 466.67% from the prior year.
- Income from Non-Controlling Interests was $5.0 million for Q1 2026 at Thermo Fisher Scientific, down from $6.0 million in the prior quarter.
- Over five years, Income from Non-Controlling Interests peaked at $6.0 million in Q2 2024 and troughed at -$24.0 million in Q4 2023.
- Average Income from Non-Controlling Interests over 5 years is -$250000.0, with a median of $3.5 million recorded in 2022.
- Year-over-year, Income from Non-Controlling Interests sank 1100.0% in 2023 and surged 500.0% in 2024.
- Over 5 years, Income from Non-Controlling Interests stood at -$2.0 million in 2022, then tumbled by 1100.0% to -$24.0 million in 2023, then jumped by 75.0% to -$6.0 million in 2024, then surged by 200.0% to $6.0 million in 2025, then slipped by 16.67% to $5.0 million in 2026.
- Per Business Quant data, the three most recent Income from Non-Controlling Interests figures were $5.0 million in Q1 2026, $6.0 million in Q4 2025, and $5.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 5.00 Mn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | - |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | - |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | - |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | - |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 1.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | - |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | - |
| 10 | Quest Diagnostics | 23.76 Bn | 23.67 Bn | 942.00 Mn | 12.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 5.00 Mn |
| Dec 31, 2025 | 6.00 Mn |
| Sep 27, 2025 | 5.00 Mn |
| Jun 28, 2025 | 2.00 Mn |
| Mar 29, 2025 | 4.00 Mn |
| Dec 31, 2024 | -6.00 Mn |
| Jun 29, 2024 | 6.00 Mn |
| Mar 30, 2024 | 4.00 Mn |
| Dec 31, 2023 | -24.00 Mn |
| Sep 30, 2023 | -20.00 Mn |
| Jul 1, 2023 | 1.00 Mn |
| Apr 1, 2023 | 3.00 Mn |
| Dec 31, 2022 | -2.00 Mn |
| Oct 1, 2022 | 3.00 Mn |
| Jul 2, 2022 | 4.00 Mn |
| Apr 2, 2022 | 5.00 Mn |
| Dec 31, 2021 | 1.00 Mn |
| Oct 2, 2021 | 1.00 Mn |
| Jul 3, 2021 | 1.00 Mn |